Mapping the Chinese version of the EORTC QLQ-BR53 onto the EQ-5D-5L and SF-6D utility scores
T Liu, S Li, M Wang, Q Sun, G Chen - The Patient-Patient-Centered …, 2020 - Springer
Objective This study aimed to develop mapping algorithms from the European Organization
for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-BR53 …
for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-BR53 …
Indirect and direct mapping of the cancer-specific EORTC QLQ-C30 onto EQ-5D-5L utility scores
A Meunier, A Soare, H Chevrou-Severac… - … Health Economics and …, 2022 - Springer
Objective The aim of this study was to develop a response mapping algorithm to predict EQ-
5D-5L utilities from European Organisation for Research and Treatment Quality of Life …
5D-5L utilities from European Organisation for Research and Treatment Quality of Life …
Mapping the cancer-specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the generic EQ-5D in metastatic breast cancer patients
E Kim, SK Ko, HY Kang - Quality of Life Research, 2012 - Springer
Purpose To develop a mapping algorithm for a conversion of the EORTC QLQ-C30 and
EORTC QLQ BR-23 into the EQ-5D-derived utilities in metastatic breast cancer (MBC) …
EORTC QLQ BR-23 into the EQ-5D-derived utilities in metastatic breast cancer (MBC) …
Testing alternative regression models to predict utilities: mapping the QLQ-C30 onto the EQ-5D-5L and the SF-6D
AN Lamu, JA Olsen - Quality of Life Research, 2018 - Springer
Purpose The purpose of the study was to compare alternative statistical techniques to find
the best approach for converting QLQ-C30 scores onto EQ-5D-5L and SF-6D utilities, and to …
the best approach for converting QLQ-C30 scores onto EQ-5D-5L and SF-6D utilities, and to …
Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients
SH Kim, MW Jo, HJ Kim, JH Ahn - Health and quality of life outcomes, 2012 - Springer
Abstract Background The European Organisation for Research and Treatment of Cancer
Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) is the instrument most frequently …
Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) is the instrument most frequently …
Mapping the functional assessment of cancer therapy-breast (FACT-B) to the 5-level EuroQoL Group's 5-dimension questionnaire (EQ-5D-5L) utility index in a multi …
YB Cheung, N Luo, R Ng, CF Lee - Health and Quality of Life Outcomes, 2014 - Springer
Purpose To develop an algorithm for mapping the Functional Assessment of Cancer
Therapy–Breast (FACT-B) to the 5-level EuroQoL Group's 5-dimension questionnaire (EQ …
Therapy–Breast (FACT-B) to the 5-level EuroQoL Group's 5-dimension questionnaire (EQ …
Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer
Background To develop direct and indirect (response) mapping algorithms from the
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire …
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire …
Mapping the FACT-G to EQ-5D-3L utility index in cancer with the Chinese values set
ZK He, WJ Liang, WJ Xu, WX Huang… - Expert Review of …, 2022 - Taylor & Francis
Objective The purpose of this research was to create a function for mapping the cancer-
specific instrument (FACT-G) to a preference-based measure (EQ-5D-3 L) utility index for …
specific instrument (FACT-G) to a preference-based measure (EQ-5D-3 L) utility index for …
Mapping the EORTC QLQ-C30 onto the EQ-5D-3L: assessing the external validity of existing mapping algorithms
B Doble, P Lorgelly - Quality of Life Research, 2016 - Springer
Purpose To determine the external validity of existing mapping algorithms for predicting EQ-
5D-3L utility values from EORTC QLQ-C30 responses and to establish their generalizability …
5D-3L utility values from EORTC QLQ-C30 responses and to establish their generalizability …
Mapping the QLQ-C30 quality of life cancer questionnaire to EQ-5D patient preferences
Abstract Background Although cancer-specific Health-Related Quality of Life (HRQOL) are
commonly included in randomized clinical trials or other prospective non-randomized …
commonly included in randomized clinical trials or other prospective non-randomized …